30.11.2017 17:45:00
|
Implanet Announces: Liquidity Contract Transferred From ODDO Corporate Finance to Tradition Securities And Futures (TSAF)
Regulatory News:
IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext Growth: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today is announcing that it has transferred the liquidity contract previously entered into with Oddo Corporate Finance to Tradition Securities And Futures (TSAF) effective December 1, 2017.
The liquidity contract entered into with TSAF complies with the AMAFI Code of Conduct for Liquidity Contracts approved by the Autorité des Marchés Financiers on March 21, 2011. The liquidity contract has been agreed for a term of one year to enhance the liquidity of trading in Implanet shares (ISIN code: FR0010458729 – Ticker: ALIMP) listed on the Euronext Growth Paris market.
The following funds and assets have been set aside for the implementation of this contract:
• €36,689.25 in cash
• 153,000 Implanet shares
About IMPLANET
Founded in 2007, IMPLANET is a medical
technology company that manufactures high-quality implants for
orthopedic surgery. Its flagship product, the JAZZ® latest-generation
implant, aims to treat spinal pathologies requiring vertebral fusion
surgery. Protected by four families of international patents, JAZZ® has
obtained 510(k) regulatory clearance from the Food and Drug
Administration (FDA) in the United States and the CE mark. IMPLANET
employs 48 staff and recorded 2016 sales of €7.8 million. For further
information, please visit www.implanet.com.
Based
near Bordeaux in France, IMPLANET established a US subsidiary in Boston
in 2013.
IMPLANET is listed on Euronext™ Growth market in Paris.
The Company would like to remind that the table for monitoring the
BEOCABSA, OCA, BSA and the number of shares outstanding, is available on
its website: http://www.implanet-invest.com/suivi-des-actions-80
View source version on businesswire.com: http://www.businesswire.com/news/home/20171130005809/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMPLANET SAmehr Nachrichten
Keine Nachrichten verfügbar. |